Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors (MANTRA-2)

NCT05012397 is registered in ClinicalTrials.gov with Rain Oncology Inc as lead sponsor.

NCT NCT05012397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors (MANTRA-2)
Lead sponsor
Rain Oncology Inc
Phase
Phase 2
Overall status
Terminated
Start date
November 1, 2021
Completion date
October 15, 2023
Enrollment
40 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

adrenocortical carcinoma, biliary tract cancer, bladder urothelial carcinoma, breast cancer invasive, cervical cancer, cholangiocarcinoma, gastric cancer, head and neck carcinoma, lung adenocarcinoma, mdm2 gene amplification, melanoma, non small cell lung cancer, ovarian carcinoma, pancreas cancer, sarcoma, solid tumors, stomach adenocarcinoma, testicular germ cell tumor